FDA Import Refusal SCS-0960957-1/61/1C — Tianjin Kingyork Pharmaceuticals Co., Ltd
The FDA refused shipment SCS-0960957-1/61/1C from Tianjin Kingyork Pharmaceuticals Co., Ltd (China) on August 11, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- August 11, 2020
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 66VBY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,75